Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Evaluation of the Therapeutic Potential of a CNP Analog in a Fgfr3 Mouse Model Recapitulating Achondroplasia
HTML
PDF
Details
Locations
Year:
2012
Type:
article
Source:
The American Journal of Human Genetics
DOI:
10.1016/j.ajhg.2012.10.014
Authors:
Florence Lorget,
Nabil Kaci,
Jeff Peng,
Catherine Benoist-Lasselin,
Emilie Mugniery,
Todd Oppeneer,
Dan J. Wendt,
Sean M. Bell,
Sherry Bullens,
Stuart Bunting,
Laurie S. Tsuruda,
Charles A. O'Neill,
Federico Di Rocco,
Arnold Munnich,
Laurence Legeai-Mallet
show all 15
Institutions:
Biohaven Pharmaceuticals (United States),
BioMarin (United States),
Hôpital Necker-Enfants Malades,
Inserm,
Sorbonne Paris Cité,
Institut des Maladies Génétiques Imagine,
Université Paris Descartes
show all 7
Language:
English
Topic:
Connective tissue disorders research
Subfield:
Genetics
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
Keywords:
achondroplasia,
FGFR3,
MAPK signaling,
ERK1/2 phosphorylation,
growth plate chondrocytes,
bone growth,
hypochondroplasia,
dwarfism
show all 8
SDG:
Good health and well-being
Open Access status:
bronze
Funders:
BioMarin Pharmaceutical,
Fondation des Gueules Cassées
OpenAlex ID:
W1972845920
FWCI:
7.492
Cites:
31
Cited by:
227
Related to:
9